Optas LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,685
| Closed | -$286K | – | 364 |
|
|
2025
Q1 | $286K | Buy |
4,685
+114
| +2% | +$6.95K | 0.05% | 207 |
|
|
2024
Q4 | $259K | Buy |
+4,571
| New | +$259K | 0.06% | 205 |
|
|
2023
Q4 | – | Sell |
-3,991
| Closed | -$232K | – | 198 |
|
|
2023
Q3 | $232K | Sell |
3,991
-541
| -12% | -$31.4K | 0.08% | 153 |
|
|
2023
Q2 | $290K | Buy |
4,532
+622
| +16% | +$39.8K | 0.1% | 122 |
|
|
2023
Q1 | $271K | Sell |
3,910
-508
| -11% | -$35.2K | 0.1% | 129 |
|
|
2022
Q4 | $318K | Sell |
4,418
-223
| -5% | -$16K | 0.13% | 104 |
|
|
2022
Q3 | $330K | Buy |
4,641
+406
| +10% | +$28.9K | 0.14% | 91 |
|
|
2022
Q2 | $326K | Buy |
4,235
+715
| +20% | +$55K | 0.13% | 100 |
|
|
2022
Q1 | $258K | Buy |
3,520
+315
| +10% | +$23.1K | 0.08% | 121 |
|
|
2021
Q4 | $200K | Buy |
+3,205
| New | +$200K | 0.06% | 143 |
|
|
2021
Q3 | – | Sell |
-3,090
| Closed | -$207K | – | 150 |
|
|
2021
Q2 | $207K | Buy |
+3,090
| New | +$207K | 0.06% | 138 |
|
|
2020
Q4 | – | Sell |
-3,909
| Closed | -$236K | – | 147 |
|
|
2020
Q3 | $236K | Buy |
3,909
+94
| +2% | +$5.68K | 0.07% | 140 |
|
|
2020
Q2 | $225K | Buy |
+3,815
| New | +$225K | 0.09% | 113 |
|